EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study

Marietta Iacucci iD, Louisa Jeffery, Animesh Acharjee iD, Enrico Grisan, Andrea Buda, Olga M Nardone iD, Samuel C L Smith, Nunzia Labarile, Davide Zardo, Bella Ungar, Stuart Hunter, Ren Mao iD und 6 weitere

Inflammatory Bowel Diseases · 01.09.2023 · 29 (9) · 1409-1420

DOI: 10.1093/ibd/izac233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 15.11.2022. Verfasst von Marietta Iacucci und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health Research Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Crohn Disease, Inflammatory Bowel Diseases, Colitis, Ulcerative, Biological Products. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to predict response to biologics in inflammatory bowel disease (IBD) using computerized image analysis of probe confocal laser endomicroscopy (pCLE) in vivo and assess the binding of fluorescent-labeled biologics ex vivo. Additionally, we investigated genes predictive of anti-tumor necrosis factor (TNF) response.

Methods

Twenty-nine patients (15 with Crohn’s disease [CD], 14 with ulcerative colitis [UC]) underwent colonoscopy with pCLE before and 12 to 14 weeks after starting anti-TNF or anti-integrin α4β7 therapy. Biopsies were taken for fluorescein isothiocyanate–labeled infliximab and vedolizumab staining and gene expression analysis. Computer-aided quantitative image analysis of pCLE was performed. Differentially expressed genes predictive of response were determined and validated in a public cohort.

Results

In vivo, vessel tortuosity, crypt morphology, and fluorescein leakage predicted response in UC (area under the receiver-operating characteristic curve [AUROC], 0.93; accuracy 85%, positive predictive value [PPV] 89%; negative predictive value [NPV] 75%) and CD (AUROC, 0.79; accuracy 80%; PPV 75%; NPV 83%) patients. Ex vivo, increased binding of labeled biologic at baseline predicted response in UC (UC) (AUROC, 83%; accuracy 77%; PPV 89%; NPV 50%) but not in Crohn’s disease (AUROC 58%). A total of 325 differentially expressed genes distinguished responders from nonresponders, 86 of which fell within the most enriched pathways. A panel including ACTN1, CXCL6, LAMA4, EMILIN1, CRIP2, CXCL13, and MAPKAPK2 showed good prediction of anti-TNF response (AUROC >0.7).

Conclusions

Higher mucosal binding of the drug target is associated with response to therapy in UC. In vivo, mucosal and microvascular changes detected by pCLE are associated with response to biologics in inflammatory bowel disease. Anti-TNF–responsive UC patients have a less inflamed and fibrotic state pretreatment. Chemotactic pathways involving CXCL6 or CXCL13 may be novel targets for therapy in nonresponders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseInflammatory Bowel DiseasesColitis, UlcerativeBiological ProductsHumansTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alphaBiological TherapyGene ExpressionFluoresceinsLasersAdaptor Proteins, Signal TransducingLIM Domain Proteins

Stichwörter der Autor:innen

Crohn’s diseaseRNA transcriptomicsartificial intelligencebiological agentsendoscopic molecular labelingprobe confocal laser endomicroscopyulcerative colitis

Substanzen

Tumor Necrosis Factor InhibitorsTumor Necrosis Factor-alphaBiological ProductsFluoresceinsCRIP2 protein, humanAdaptor Proteins, Signal TransducingLIM Domain Proteins

Autor:innen und Institutionen

  • National Institute for Health Research Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.
  • Gastroenterology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • National Institute for Health Research Surgical Reconstruction, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Department of Information Engineering, University of Padova, Padova, Italy.

ORCID-Profile: Marietta Iacucci, Animesh Acharjee, Olga M Nardone, Ren Mao, Tommaso Lorenzo Parigi, Subrata Ghosh

Zitieren

APA

Iacucci, M., Jeffery, L., Acharjee, A., Grisan, E., Buda, A., Nardone, O. M., Smith, S. C. L., Labarile, N., Zardo, D., Ungar, B., Hunter, S., Mao, R., Cannatelli, R., Shivaji, U. N., Parigi, T. L., Reynolds, G. M., Gkoutos, G. V., & Ghosh, S. (2023). Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study. Inflammatory Bowel Diseases, 29(9), 1409-1420. https://doi.org/10.1093/ibd/izac233

Vancouver

Iacucci M, Jeffery L, Acharjee A, Grisan E, Buda A, Nardone OM, et al. Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study. Inflammatory Bowel Diseases. 2023;29(9):1409-1420. doi:10.1093/ibd/izac233

BibTeX
@article{Iacucci2023,
  author = {Iacucci, Marietta and Jeffery, Louisa and Acharjee, Animesh and Grisan, Enrico and Buda, Andrea and Nardone, Olga M and Smith, Samuel C L and Labarile, Nunzia and Zardo, Davide and Ungar, Bella and Hunter, Stuart and Mao, Ren and Cannatelli, Rosanna and Shivaji, Uday N and Parigi, Tommaso Lorenzo and Reynolds, Gary M and Gkoutos, Georgios V and Ghosh, Subrata},
  title = {Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  volume = {29},
  number = {9},
  pages = {1409--1420},
  doi = {10.1093/ibd/izac233}
}
Kostenlos starten →